AstraZeneca plc 5.4% Potential Upside Indicated by Jefferies International

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

AstraZeneca plc using EPIC/TICKER code (LON:AZN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘HOLD’ this morning by analysts at Jefferies International. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Jefferies International have set a target price of 6350 GBX on its stock. This now indicates the analyst believes there is a possible upside of 5.4% from today’s opening price of 6023 GBX. Over the last 30 and 90 trading days the company share price has increased 115 points and decreased 177 points respectively. The 1 year high for the share price is 6540 GBX while the 52 week low is 5110 GBX.

AstraZeneca plc has a 50 day moving average of 6,082.28 GBX and a 200 day moving average of 5,991.80. There are currently 4,987,806,108 shares in issue with the average daily volume traded being 2,494,450. Market capitalisation for LON:AZN is £79,308,960,748 GBP.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials.
    AstraZeneca's Imfinzi receives FDA approval for limited-stage small cell lung cancer, marking a significant breakthrough in extending patient survival.
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.

      Search

      Search